Disease Control Data, nr-axSpA
Por um escritor misterioso
Descrição
Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.
Frontiers Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics
Comparison of clinical characteristics between adult-onset and juvenile-onset non-radiographic axial spondyloarthritis in Chinese patients: results from the COCAS cohort, European Journal of Medical Research
Gender Differences in Baseline Clinical Characteristics Among Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis: Data from 3 Randomized Ixekizumab Controlled Trials - ACR Meeting Abstracts
Improving the design of RCTs in non-radiographic axial spondyloarthritis
Disease Control Data, nr-axSpA
Axial spondyloarthritis: concept, construct, classification and implications for therapy
Disease Control Data, nr-axSpA
Axial Spondyloarthritis RINVOQ® (upadacitinib)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
